Verrica Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CALIGAN PARTNERS LP | 08/14/2026 | 923.91 K | $5.65 M | 0.00% | 4.34% |
| CANNELL CAPITAL LLC | 08/18/2026 | 783.92 K | $4.80 M | 14.42% | 3.68% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 707.34 K | $4.33 M | 0.00% | 3.32% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 471.56 K | $2.89 M | 0.00% | 2.21% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 426.30 K | $2.61 M | -17.73% | 2.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 280.73 K | $1.72 M | 0.00% | 1.32% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 279.31 K | $1.71 M | 47.97% | 1.31% |
| MARINER, LLC | 08/13/2026 | 207.23 K | $1.27 M | 744.32% | 0.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 138.16 K | $845.66 K | -0.54% | 0.65% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/14/2026 | 88.42 K | $241.45 K | -11.35% | 0.42% |
| BLACKROCK, INC. | 08/07/2026 | 74.34 K | $454.99 K | 92.84% | 0.35% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 70.17 K | $429.46 K | 7.79% | 0.33% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 40.83 K | $249.85 K | -19.42% | 0.19% |
| STATE STREET CORP | 08/07/2026 | 28.92 K | $176.97 K | 0.00% | 0.14% |
| NORTHERN TRUST CORP | 08/13/2026 | 27.00 K | $165.22 K | -14.52% | 0.13% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 23.75 K | $145.35 K | -84.55% | 0.11% |
| JANE STREET GROUP, LLC | 08/14/2026 | 23.65 K | $144.76 K | -51.93% | 0.11% |
| VERDAD ADVISERS, LP | 08/14/2026 | 23.07 K | $141.18 K | 90.68% | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 21.77 K | $133.23 K | -32.73% | 0.10% |
| LEGACY TRUST | 07/31/2026 | 16.58 K | $101.49 K | -3.77% | 0.08% |
| FIFTH THIRD BANCORP | 08/05/2026 | 14.00 K | $85.68 K | 100.00% | 0.07% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 13.89 K | $85.00 K | 100.00% | 0.07% |
| XTX TOPCO LTD | 08/14/2026 | 13.72 K | $83.99 K | 100.00% | 0.06% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 13.05 K | $79.84 K | 100.00% | 0.06% |
| HRT FINANCIAL LP | 08/14/2026 | 13.02 K | $79.00 K | 100.00% | 0.06% |
| BECK MACK & OLIVER LLC | 08/14/2026 | 12.00 K | $73.44 K | 0.00% | 0.06% |
| UBS GROUP AG | 08/13/2026 | 6.07 K | $37.16 K | 42.18% | 0.03% |
| MORGAN STANLEY | 08/13/2026 | 3.20 K | $19.59 K | -85.70% | 0.02% |
| CAPITAL ANALYSTS, LLC | 08/05/2026 | 1.50 K | $9.00 K | 0.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 862 | $5.28 K | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2026 | 764 | $5.00 K | -20.83% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 614 | $3.76 K | -28.27% | 0.00% |
| SALOMON & LUDWIN, LLC | 08/07/2026 | 290 | $1.72 K | 0.00% | 0.00% |
| ALLIED PRIVATE WEALTH LLC | 07/09/2026 | 202 | $1.34 K | 100.00% | 0.00% |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 07/27/2026 | 200 | $1.22 K | 0.00% | 0.00% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 07/22/2026 | 175 | $1.04 K | 0.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 07/20/2026 | 127 | $777 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 110 | $673 | 0.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 08/07/2026 | 102 | $624 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 64 | $392 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 47 | $306 | 0.00% | 0.00% |
| AMERITAS ADVISORY SERVICES, LLC | 08/14/2026 | 30 | $184 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 26 | $178 | 0.00% | 0.00% |
| VALLEY NATIONAL ADVISERS INC | 07/29/2026 | 25 | $153 | 100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| OPTIVER HOLDING B.V. | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Verrica Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 62 institutional investors and hedge funds held shares of Verrica Pharmaceuticals Inc. The most heavily invested institutionals were:
Caligan Partners LP: 923,910
CANNELL CAPITAL LLC: 783,923
Affinity Asset Advisors, LLC: 707,338
Velan Capital Investment Management LP: 471,559
ARMISTICE CAPITAL, LLC: 426,304
BOOTHBAY FUND MANAGEMENT, LLC: 280,734
22.30% of Verrica Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.19 M shares in the last 24 months. This purchase volume represents approximately $35.17 M in transactions.